CDKN2A and neoplasm: Senescence is characterized in particular by increased expression of p16INK4A and p21CIP1, two cyclin-dependent kinase inhibitors (CDKI) involved in the two major tumor suppressor pathways enabling permanent and irreversible cell cycle arrest [43].